Bank of Kentucky’s Novartis NVS Stock Holding History

Bank of Kentucky’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$209K	Hold	2,368	–	–	0.05%	95
2014 Q4	$197K	Hold	2,368	–	–	0.04%	93
2014 Q3	$199K	Hold	2,368	–	–	0.04%	89
2014 Q2	$192K	Hold	2,368	–	–	0.04%	88
2014 Q1	$181K	Buy	2,368 +926	+64%	+$67.5K	0.04%	87
2013 Q4	$103K	Hold	1,442	–	–	0.03%	105
2013 Q3	$99K	Hold	1,442	–	–	0.03%	106
2013 Q2	$92K	Buy	+1,442	New	+$93.8K	0.03%	103

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BTS

BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Kentucky's NVS Position: Q1 2015 in Review

Bank of Kentucky held its Novartis (NVS) position steady in Q1 2015 at 2,368 shares worth $209K. The position accounts for 0.05% of the portfolio, ranked #95.

Bank of Kentucky first reported a position in NVS in Q2 2013 and has held it in 8 quarters since. 940 funds tracked by Wall St. Rank hold NVS as of Q1 2015.

Bank of Kentucky held 2,368 shares of Novartis worth $209K as of Q1 2015.
Bank of Kentucky left its Novartis share count unchanged in Q1 2015.
Novartis made up 0.05% of Bank of Kentucky's portfolio in Q1 2015, its #95 holding.
Bank of Kentucky first reported a position in Novartis in Q2 2013 and has held it in 8 quarters since.
940 funds tracked by Wall St. Rank held Novartis as of Q1 2015.

Based on Bank of Kentucky's 13F filing for Q1 2015, filed 28 Apr 2015.